The ownership structure has changed in the Pharmaceutical Standard. The main shareholder transferred 6% of the shares to a group of individuals. Such data is contained in the company's published financial statements.
In 2023, the main shareholder (Viktor Kharitonin is called the owner of the company in the press) reduced his share in Pharmstandard JSC from 99.99% to 96%. The accounts do not disclose the names of the new shareholders, it is only indicated that these are individuals.
Pharmstandard is a pharmaceutical company in Russia engaged in the development and production of medicines. The revenue of Pharmstandard JSC for 2023 amounted to 143 billion rubles, net profit - 23 billion rubles.
More news is on the Telegram channel "Mergers and Acquisitions. AK&M».
